Goodwin, Rachel
Jonker, Derek
Chen, Eric
Kennecke, Hagen
Cabanero, Michael
Tsao, Ming-Sound
Vickers, Michael
Bohemier, Caryn
Lim, Howard
Ritter, Heather
Tu, Dongsheng
Seymour, Lesley
Funding for this research was provided by:
Canadian Cancer Society Research Institute (#021039)
Article History
Received: 8 February 2019
Accepted: 7 June 2019
First Online: 10 September 2019
Compliance with ethical standards
:
: R Goodwin: Honorarium Novartis, Honorarium Amgen.D Jonker: No conflicts of interest.E. Chen: No conflicts of Interest.H Kennecke: No Conflicts of Interest.M Cabanero: No conflicts of Interest.M Tsao: No conflicts of interest.M Vickers: No Conflicts of Interest.C Bohemier: No Conflicts of Interest.H Lim: No conflicts of Interest.H Ritter: No Conflicts of Interest.D Tu: No Conflicts of Interest.L Seymour: Funding to support conduct of the trial.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.